(Q43758874)

26 November 2017

Blood-pressure lowering for the secondary prevention of stroke (English)

1 reference

26 November 2017

1

1 reference

26 November 2017

J Wang

2

1 reference

PubMed ID

11589927

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

358

1 reference

26 November 2017

1026-1027

1 reference

26 November 2017

9287

1 reference

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906226-2

7 January 2021

Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906226-2

7 January 2021

Why are strokes related to hypertension? Classic studies and hypotheses revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906226-2

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906226-2

7 January 2021

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906226-2

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906226-2

7 January 2021

10.1016/S0140-6736(01)06226-2

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11589927